BG Medicine, Inc. (BGMD) Announces Publication of Two Studies on Galectin-3 Test
BG Medicine is a diagnostics company focused on the development and commercialization of novel cardiovascular tests. The company has two products: the Galectin-3 test for use in patients with chronic heart failure and the CardioSCORE test for the risk prediction of major cardiovascular events. The company today announced the publication of two studies (in the United States and Europe) demonstrating the clinical utility of repeated galectin-3 testing as a useful tool in the assessment of patients with heart failure. The studies, which involved more than 3,300 subjects, demonstrated clearly that periodic evaluation of galectin-3 levels helped doctors identify those patients…